Acetaminophen

Analgesic and Antipyretic Non-opioid analgesic, para-aminophenol derivative

Dosage & Administration Guidelines

Species Route Dose Frequency Duration & Clinical Notes
Dog PO 10-15 mg/kg q8-12h Duration: As needed for pain/fever, usually 3-5 days
Notes: Use with caution in dogs with liver disease. Do not exceed 15 mg/kg per dose. Monitor for signs of toxicity.

Clinical Indications & Species Uses

General Indications
  • Analgesic and antipyretic in dogs only; not recommended in other species due to toxicity
Dog (Canine)
  • Mild to moderate pain
  • Fever reduction
  • As an alternative to NSAIDs when NSAIDs are contraindicated (e.g., GI ulcers, renal disease)

Pharmacology & Mechanism of Action

Drug Class: Analgesic and Antipyretic | Pharmacological Group: Non-opioid analgesic, para-aminophenol derivative

Mechanism of Action: Acetaminophen (paracetamol) primarily acts centrally to inhibit cyclooxygenase (COX) enzymes, particularly COX-2, reducing prostaglandin synthesis in the central nervous system. It has weak peripheral anti-inflammatory activity. Its analgesic effect is mediated through modulation of the descending serotonergic pathways and inhibition of nitric oxide synthesis. Antipyretic effect is due to inhibition of prostaglandin synthesis in the hypothalamus, leading to vasodilation and increased heat dissipation.

Pharmacodynamics: Acetaminophen provides effective analgesia and antipyresis with minimal anti-inflammatory action. It does not affect platelet function or gastric mucosal integrity, making it safer than NSAIDs in certain patients. In dogs, it is used for pain and fever, but its efficacy is less than that of NSAIDs for inflammatory pain. In cats, it is extremely toxic due to deficient glucuronidation and increased susceptibility to oxidative damage.

⚡ Pharmacokinetics Summary

Absorption: Rapidly and completely absorbed from the gastrointestinal tract after oral administration. Peak plasma concentrations occur within 30-60 minutes in dogs. Bioavailability is high (near 100%) in dogs.
Distribution: Widely distributed throughout body tissues and fluids. Protein binding is low (10-30%). Crosses the blood-brain barrier and placenta. Volume of distribution is approximately 0.8-1.0 L/kg in dogs.
Metabolism: Metabolized primarily in the liver via glucuronidation and sulfation. In dogs, glucuronidation is the major pathway. A minor pathway via cytochrome P450 (CYP2E1) produces the reactive metabolite N-acetyl-p-benzoquinone imine (NAPQI), which is normally detoxified by glutathione. In cats, glucuronidation is deficient, leading to increased sulfation and greater production of NAPQI, causing severe toxicity.
Excretion: Renal excretion of metabolites (glucuronide and sulfate conjugates) and small amounts of unchanged drug. In dogs, elimination half-life is approximately 2-4 hours. In cats, half-life is prolonged (2-5 hours) and toxicity occurs at much lower doses.
Half-Life: Dogs: 2-4 hours; Cats: 2-5 hours (but toxic effects occur at low doses); Horses: 3-4 hours (limited use)
Bioavailability: Oral: ~100% in dogs; variable in other species
Protein Binding: 10-30%

Available Formulations & Strengths

Oral Tablet 325 mg, 500 mg, 650 mg (PO)
Oral Liquid/Suspension 160 mg/5 mL, 325 mg/10 mL (PO)
Oral Capsule 325 mg, 500 mg (PO)

Contraindications & Clinical Warnings

Contraindications:
  • Cats and other felids (absolute contraindication due to severe toxicity)
  • Known hypersensitivity to acetaminophen
  • Severe hepatic impairment
  • Severe renal impairment (use with caution)
  • Concurrent use of other hepatotoxic drugs
Warnings & Clinical Precautions:
  • Do not use in cats or other species with deficient glucuronidation (e.g., ferrets)
  • Use with caution in dogs with pre-existing liver disease, glucose-6-phosphate dehydrogenase deficiency, or dehydration
  • Avoid prolonged use (>5 days) without veterinary supervision
  • Monitor for signs of hepatotoxicity (vomiting, jaundice, lethargy) during therapy
  • Do not combine with other acetaminophen-containing products
  • Keep out of reach of pets; accidental ingestion in cats can be fatal

Adverse Effects & Reactions

Common:

  • Gastrointestinal upset (vomiting, diarrhea)
  • Loss of appetite
  • Lethargy

Serious / Severe:

  • Hepatotoxicity (liver necrosis)
  • Methemoglobinemia (especially in cats)
  • Renal damage
  • Fulminant hepatic failure

Rare:

  • Allergic reactions (urticaria, angioedema)
  • Blood dyscrasias (thrombocytopenia, leukopenia)

Key Drug Interactions

Interacting Drug / Class Clinical Effect & Mechanism Severity
NSAIDs (e.g., carprofen, meloxicam) Increased risk of gastrointestinal ulceration and renal toxicity Moderate
Phenobarbital and other CYP inducers Increased production of toxic metabolite NAPQI, enhancing hepatotoxicity High
Warfarin and other anticoagulants Acetaminophen may potentiate anticoagulant effect Moderate
Chloramphenicol May increase half-life of acetaminophen Mild

Overdose & Toxicity Management

Signs of Toxicity:

  • Vomiting
  • Lethargy
  • Abdominal pain
  • Jaundice
  • Methemoglobinemia (cyanosis, chocolate-colored blood)
  • Hepatic necrosis
  • Renal failure
  • Coma and death in severe cases

Emergency Treatment Protocol: Immediate decontamination (induction of vomiting if within 2 hours, activated charcoal). Administer N-acetylcysteine (NAC) as a glutathione precursor: loading dose 140 mg/kg PO/IV, then 70 mg/kg q4h for 7-10 doses. For methemoglobinemia, administer methylene blue (1-2 mg/kg IV) or ascorbic acid (20-30 mg/kg PO/IV). Provide supportive care: IV fluids, oxygen therapy, liver protectants (S-adenosylmethionine, silymarin). Monitor liver enzymes, methemoglobin levels, and renal function. Prognosis is guarded if treatment is delayed.

Food Animal Withdrawal Times

Not approved for use in food animals; no withdrawal times established. Do not use in food-producing animals.

Storage, Handling & Regulatory Information

Storage Temperature: Store at room temperature (20-25°C), protect from moisture

Handling & Special Conditions: Keep container tightly closed. Store away from heat and direct sunlight.

Dispensing Status: Over-The-Counter (OTC)

Approval Status: Not FDA-approved for veterinary use; approved for human use only.

Extra-Label (Off-Label) Use: In the US, acetaminophen is not FDA-approved for veterinary use, but extra-label use in dogs is permitted under AMDUCA with a valid veterinary-client-patient relationship. Use in cats is prohibited due to toxicity. For food animals, extra-label use is prohibited.

Clinical Pearls & Practice Notes

💡 Clinical Insights: Acetaminophen is a useful analgesic and antipyretic in dogs, particularly when NSAIDs are contraindicated. However, it has a narrow margin of safety in dogs and is extremely toxic to cats. Always confirm the species before prescribing. Use the lowest effective dose for the shortest duration. Educate owners about the risks of accidental ingestion, especially in multi-pet households. Monitor liver function during prolonged therapy. In cases of overdose, immediate treatment with N-acetylcysteine is critical. Due to the availability of safer alternatives (e.g., NSAIDs, opioids), acetaminophen is not a first-line analgesic in veterinary medicine.

References & Literature

  • 📚 Plumb's Veterinary Drug Handbook
  • 📚 Papich Veterinary Pharmacology and Therapeutics
  • 📚 Compendium of Veterinary Products (CVP)